Shandong Boyuan Pharmaceutical Co., Ltd. logo

Shandong Boyuan Pharmaceutical Co., Ltd. (301617)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
47. 07
-0.84
-1.7533%
¥
4.97B Market Cap
- P/E Ratio
- Div Yield
1.02M Volume
- Eps
¥ 47.91
Previous Close
Add Transaction
Day Range
46.88 48.12
Year Range
30.42 84.62
Want to track 301617 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

301617 closed today lower at ¥47.07, a decrease of -1.7533% from yesterday's close, completing a monthly decrease of -19.6621% or -¥11.52. Over the past 12 months, 301617 stock lost -38.8701%.
301617 is not paying dividends to its shareholders.
Shandong Boyuan Pharmaceutical Co., Ltd. has completed 2 stock splits, with the recent split occurring on May 26, 2026.
The company's stock is traded on one exchange.

301617 Chart

People also search for

Guangzhou Wondfo Biotech Co., Ltd.
¥ 17.74
-0.8385%
China Reform Health Management Co., Ltd.
¥ 7.42
-1.5915%
Acro Biosystems Co., Ltd.
¥ 82.3
+5.9202%
EIT Environmental Development Group Co., Ltd.
¥ 16.48
-1.3764%
Huapont Life Sciences Co., Ltd.
¥ 4.5
+0.6711%

Shandong Boyuan Pharmaceutical Co., Ltd. (301617) FAQ

What is the stock price today?

The current price is ¥47.07.

On which exchange is it traded?

Shandong Boyuan Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 301617.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 4.97B.

Has Shandong Boyuan Pharmaceutical Co., Ltd. ever had a stock split?

Shandong Boyuan Pharmaceutical Co., Ltd. had 2 splits and the recent split was on May 26, 2026.

Shandong Boyuan Pharmaceutical Co., Ltd. Profile

Pharmaceuticals Industry
Healthcare Sector
- CEO
XSHE Exchange
- ISIN
China Country
- Employees
- Last Dividend
26 May 2026 Last Split
- IPO Date

Overview

Shandong Boyuan Pharmaceutical Co., Ltd. stands out as a prominent figure in the pharmaceutical industry, focusing on the research, development, production, and sales of various pharmaceutical products. The company is committed to improving public health through innovation and maintaining high standards in pharmaceutical manufacturing. With a broad range of medications in its portfolio, Shandong Boyuan serves both the domestic and international markets, significantly contributing to the global healthcare landscape. Its dedication to excellence and ongoing improvement underlines its pivotal role in increasing the accessibility of vital medicines and promoting sustainable health solutions.

Products and Services

Shandong Boyuan Pharmaceutical Co., Ltd. offers a wide array of medications, covering various therapeutic areas to meet the diverse needs of the healthcare sector. These include:

  • Innovative Drugs: Focusing on the discovery and development of novel pharmaceuticals, Shandong Boyuan is at the forefront of bringing groundbreaking treatments to market. This area of their portfolio is dedicated to addressing unmet medical needs and offering newer, more effective options for disease management.
  • Generic Medications: The company produces high-quality generic drugs that provide cost-effective solutions for healthcare. By ensuring the availability of generic versions of popular medications, Shandong Boyuan helps to make essential drugs more accessible to a wider audience, thereby supporting global health initiatives.
  • Over-the-Counter (OTC) Products: Aside from prescription medicines, Shandong Boyuan also offers a range of OTC healthcare products. These include vitamins, supplements, and other non-prescription medications that support overall health and well-being.
  • International Distribution: With a dedication to meeting the healthcare needs of populations globally, Shandong Boyuan has established an extensive distribution network that allows its pharmaceutical products to reach international markets. This not only expands the company's impact on global health but also reinforces its position as a key player in the international pharmaceutical industry.

Contact Information

Address: -
Phone: -